Smoking cessation program in Hong Kong workplaces

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This program aims to enhance smoking cessation among employees in Hong Kong through a combination of mobile phone-based interventions, health talks, brief phone counseling, and nicotine replacement therapy. The study is divided into two phases: the first phase involves a cross-sectional survey to assess employers' knowledge and practices regarding smoking cessation, while the second phase is a randomized controlled trial evaluating the effectiveness of the intervention. The primary outcome is self-reported abstinence from smoking at various follow-up points, alongside secondary outcomes related to mental health and smoking reduction.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Hong Kong residents aged 18 or above
2. Current smoking cigarettes or alternative tobacco products daily with an exhaled carbon monoxide level ≥4 ppm or a positive salivary cotinine test
3. Able to communicate in Cantonese/Mandarin and read Chinese
4. Able to use instant messaging tool (e.g. WhatsApp) for communication.
5. Stay in Hong Kong during the intervention and follow-up periods (12 months)

Exclusion Criteria:

1. Smokers who are psychologically or physically unable to communicate
2. Currently following other SC program(s)
3. Having used NRT for the past month
4. Having severe angina, serious cardiac arrhythmias and hypertension
5. Have acute myocardial event in the past month
6. Being pregnant or providing breastfeeding

Where it's running

• School of Nursing, The University of Hong Kong
  Hong Kong, Hong Kong Recruiting

Study contacts

• Principal investigator: Man Ping Wang — The University of Hong Kong
• Study coordinator: Man Ping Wang
• Email: mpwang@hku.hk
• Phone: 85239176636

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Quitting Matters: a smoking quit program for people living with HIV

  This 6-month program will test whether a tailored smartphone app plus nicotine patches and gum helps people living with HIV quit smoking better than a standard quit app.

  Recruiting Wake Forest University Health Sciences · Winston-Salem, North Carolina · NCT06883097

• Smoky Futures: Danish Adolescent Nicotine Use over Time

  This observational cohort follows Danish youths ages 15–25 to see how cigarette, e-cigarette, and other nicotine use begin, change, and affect health and education over several years.

  Recruiting University of Southern Denmark · Copenhagen · NCT07910331

• Nicotine Orodispersible Tablet to Relieve Cravings in Smokers

  A nicotine mint orodispersible tablet is tested vs placebo to see if it quickly eases the urge to smoke in adult cigarette smokers.

  Recruiting Phase 2 Kenvue Brands LLC · Mississauga, Ontario · NCT07893158

• Optimizing when weekly chatbot reminders go out to people using a chatbot for quitting smoking

  This study tests whether sending weekly reminders at different times helps people stay engaged with a chatbot smoking-cessation service.

  Recruiting The University of Hong Kong · Hong Kong · NCT07826884

• NMDA and Sigma-1 combination therapy for smoking cessation with AXS-05

  This phase 3 trial tests whether AXS-05 can help adults quit smoking better than placebo or bupropion.

  Recruiting at 28 sites Phase 3 Axsome Therapeutics, Inc. · Phoenix, Arizona and 27 other locations · NCT07766655

• AI-assisted interactive case-based training to improve smoking cessation counseling by medical interns

  This study tests whether AI-powered interactive case-based training helps medical interns provide better smoking cessation counseling.

  Recruiting Assiut University · Asyut, Assuit · NCT07650721

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.